Walmart Allergy Relief D Extended-Release Tablets Recalled for Failed Dissolution
Dr. Reddy's Laboratories is recalling Walmart brand Allergy Relief D extended-release tablets (Lot #AC2103329B) nationwide because the tablets failed to meet dissolution specifications, which may affect medication effectiveness.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for a manufacturing/quality defect (failed dissolution specifications) with no reported illnesses or injuries. The hazard is theoretical—potential reduced efficacy—making this a precautionary recall appropriate for a Moderate severity rating.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Allergy Relief D Fexofenadine HCl 60 mg / Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP, distributed by Walmart Inc. The recall affects 9,984 cartons of 30-tablet bottles (NDC 49035-273-30) distributed nationwide in the USA.
The recall was initiated because the tablets failed to meet dissolution specifications. Dissolution specifications ensure that medication dissolves properly in the body at the intended rate, allowing the active ingredients to be absorbed as designed.
Consumers who have purchased this product should stop using it and consult their healthcare provider or pharmacist about obtaining a replacement or alternative medication. The affected lot number is AC2103329B, and the product was manufactured in India.
The recalled product
- Product
- Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets, USP, 30 Extended-Release Tablets USP, Distributed By Walmart Inc., Bentonville, AR 72716, Product of India, NDC 49035-273-30.
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Allergy / Decongestant
- Hazard
- dissolution-failure
- reduced-efficacy
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: AC2103329B
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27